Clinical trialNCT03325985CompletedInterventional

Emergency Medicine Palliative Care Access

SponsorNYU Langone HealthEnrollment1,606Advanced CancerEnd Stage Organ Failure

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a two-arm, multi-site randomized controlled trial of 1,350 older adults (50+ years) with either advanced cancer (defined as metastatic solid tumor) or poor prognosis end-stage organ failure (New York Heart Association (NYHA) Class III or IV Congestive Heart Failure (CHF), End-Stage Renal Disease (ESRD), defined as Glomerular Filtration Rate (GFR) \< 15 ml/min/m2 or dialysis ; or Global Initiative for Chronic Obstructive Lung Disease (GOLD) Stage III or higher, or oxygen-dependent chronic obstructive pulmonary disease (COPD) who present to the Emergency Department (ED), along with 675 of their informal caregivers. Investigators will compare the effectiveness of two distinct palliative care models: a) nurse-led telephonic case management; and b) facilitated, outpatient specialty palliative care.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Corita R. Grudzen, MD, MSHS, FACEP
Memorial Sloan Kettering Cancer Center
Principal Investigator
clinicaltrials.gov ↗
Keith S. Goldfeld, DrPH, MS, MPA
NYU Langone Health
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of California, Los Angeles Ronald Reagan Medical Center
Los Angeles, California, United States
University of California Irvine Medical Center
Orange, California, United States
University of California San Diego Medical Center
San Diego, California, United States
Yale University
New Haven, Connecticut, United States
University of Florida (uf)
Gainesville, Florida, United States
Northwestern Memorial Hospital
Chicago, Illinois, United States
Rush University Medical Center
Chicago, Illinois, United States
Brigham and Women'S Hospital/dana-Farber Cancer Institute
Boston, Massachusetts, United States
Henry Ford Health System
Detroit, Michigan, United States
Beaumont Health
Royal Oak, Michigan, United States
William Beaumont Hospital, Troy
Troy, Michigan, United States
Hackensack University Medical Center
Hackensack, New Jersey, United States
Atlantic Health System, Morristown Medical Center
Morristown, New Jersey, United States
Nyu Langone Hospital- Brooklyn
Brooklyn, New York, United States
Nyu Langone Health Hospital Long Island
Mineola, New York, United States
Bellevue Hospital
New York, New York, United States
New York University Langone Tisch Hospital
New York, New York, United States
Ohio State University (osu)
Columbus, Ohio, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 28 Mar 2018
Primary completion: 24 Aug 2023
Completion: 24 Aug 2023
Last update posted: 13 Jan 2025
Registered enrollment: 1,606
Registry id: NCT03325985

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.